Eli Lilly is making its biggest acquisition in years, devoting part of its GLP-1 cash influx to buy Centessa Pharmaceuticals and its experimental medicines for sleep disorders and neurological conditions.
The …
Sleep disorder specialist Centessa is heading for an acquisition by Eli Lilly, which has offered $6.3bn for the US and UK-based biotech.
Merck is tasking a 10-person biotech to hunt for new human antibody candidates. The drug giant will ship up to $838 million to the startup,
You can now pay for Wegovy shots and pills just like you pay for an Amazon Prime subscription. Novo Nordisk said patients paying cash can
The EU has approved UCB’s Kygevi for rare disease TK2d, and Sanofi’s acute GvHD therapy Rezurock, in a pair of decisions announced this morning.
Biogen has made a $5.6 billion deal to acquire Apellis Pharmaceuticals, the companies announced Tuesday. The deal will allow Biogen to get hold of the
Eli Lilly is making its biggest acquisition in years, devoting part of its GLP-1 cash influx to buy Centessa Pharmaceuticals and its experimental medicines for sleep disorders and neurological conditions.
The …